Add Company
Join Now

PathAdvantage Revenue and Competitors

License our Company Data API

Location

N/A

Total Funding

Medical Offices

Industry

Estimated Revenue & Valuation

  • PathAdvantage's estimated annual revenue is currently $14.6M per year.(i)
  • PathAdvantage's estimated revenue per employee is $243,000

Employee Data

  • PathAdvantage has 60 Employees.(i)
  • PathAdvantage grew their employee count by 5% last year.

PathAdvantage's People

NameTitleEmail/Phone
1
Associate Medical DirectorReveal Email/Phone
2
Medical DirectorReveal Email/Phone
3
Cytology ManagerReveal Email/Phone
4
Sales ManagerReveal Email/Phone
5
CytotechnologistReveal Email/Phone
6
CytotechnologistReveal Email/Phone
7
Phlebotomy SpecialistReveal Email/Phone
8
Billing SupervisorReveal Email/Phone
9
Microbiology Laboratory TechnologistReveal Email/Phone
10
CytotechnologistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$15.8M65-21%N/AN/A
#2
$7.8M360%N/AN/A
#3
$2.9M18-49%N/AN/A
#4
$48.7M1645%N/AN/A
#5
$27M1002%N/AN/A
#6
$73.4M2471%N/AN/A
#7
$13.9M59-8%$9.7MN/A
#8
$63.3M2135%N/AN/A
#9
$7.6M35-3%N/AN/A
#10
$1.8M11-8%N/AN/A
Add Company

What Is PathAdvantage?

Pathologist-owned lab with a difference—real people, exemplary quality of care, unmatched expertise. PathAdvantage is a pathologist owned and directed medical practice that offers complete anatomic and clinical pathology services to Texas. Staffed by a large team of specialized pathologists, we are proud to treat your patients with the same respect and thoughtfulness that you do, continuing the quality of your care while providing exemplary services such as one-day turnaround, anytime access to pathologists, and in-network status with all insurance plans. We offer a complete menu of services covering the full spectrum of anatomic and clinical pathology. This includes but is not limited to genetic, prenatal and molecular testing for inherited and acquired disorders, a complete clinical laboratory for metabolic, hormonal and infectious disease testing and of course microscopic examination of biopsy and cytology specimens.

keywords:N/A

N/A

Total Funding

60

Number of Employees

$14.6M

Revenue (est)

5%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$12.3M60-12%N/A
#2
$11.9M60N/AN/A
#3
$15.7M609%N/A
#4
$17.6M605%N/A
#5
$10.9M60-3%N/A